Skip to main content
Fig. 2 | BMC Musculoskeletal Disorders

Fig. 2

From: Evaluation of the expression pattern and diagnostic value of PPARγ in malignant and benign primary bone tumors

Fig. 2

The assessed PPARγ mRNA expression levels in malignant tumor for the different clinic-pathological variables. The PPARγ mRNA expression level was evaluated in tumor tissue of osteosarcoma and Ewing Sarcoma patients with chemotherapy status (a), metastasis (b), tumor grade (c) and tumor recurrence (d). The type of tumor is indicated above the columns. The statistical differences between groups are shown as asterisk (**= P < 0.01) and (ns) indicates non-specific

Back to article page